These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 15618041
1. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS, OPTIMAAL investigators. Eur Heart J; 2005 Feb; 26(4):350-6. PubMed ID: 15618041 [Abstract] [Full Text] [Related]
2. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ. Heart; 2010 Jun; 96(11):838-42. PubMed ID: 20406769 [Abstract] [Full Text] [Related]
3. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA, Survival and Ventricular Enlargement Trial. Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009 [Abstract] [Full Text] [Related]
9. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator. Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC. Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649 [Abstract] [Full Text] [Related]
10. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K. J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531 [Abstract] [Full Text] [Related]
11. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. J Am Coll Cardiol; 2005 Mar 01; 45(5):712-9. PubMed ID: 15734615 [Abstract] [Full Text] [Related]
12. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A, ALLHAT Collaborative Research Group. J Am Coll Cardiol; 2009 Nov 24; 54(22):2023-31. PubMed ID: 19926008 [Abstract] [Full Text] [Related]
13. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients. Trappolini M, Scorza A, Chillotti FM, Trappolini F, Danese A, De Vito F, Luberti E, Angrisani L, Braucci S. Minerva Cardioangiol; 2006 Aug 24; 54(4):471-9. PubMed ID: 17016418 [Abstract] [Full Text] [Related]
14. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan. Belonje AM, Westenbrink BD, Voors AA, von Haehling S, Ponikowski P, Anker SD, van Veldhuisen DJ, Dickstein K. Am Heart J; 2009 Jan 24; 157(1):91-6. PubMed ID: 19081402 [Abstract] [Full Text] [Related]
15. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Circulation; 2003 Jun 17; 107(23):2926-31. PubMed ID: 12771010 [Abstract] [Full Text] [Related]
16. Significance of recurrences of new atrial fibrillation in acute myocardial infarction. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, Vojvodic A, Marinkovic J, Ostojic M, Vasiljevic Z. Int J Cardiol; 2006 May 10; 109(2):235-40. PubMed ID: 16005995 [Abstract] [Full Text] [Related]
17. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB. J Am Coll Cardiol; 2005 Mar 01; 45(5):705-11. PubMed ID: 15734614 [Abstract] [Full Text] [Related]
18. Transient atrial fibrillation and risk of stroke after acute myocardial infarction. Bishara R, Telman G, Bahouth F, Lessick J, Aronson D. Thromb Haemost; 2011 Nov 01; 106(5):877-84. PubMed ID: 21866303 [Abstract] [Full Text] [Related]
19. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD. Eur Heart J; 2007 Feb 01; 28(3):326-33. PubMed ID: 17251259 [Abstract] [Full Text] [Related]
20. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U, Lindbäck J, Wallentin L, RIKS-HIA Registry. Circulation; 2005 Nov 22; 112(21):3225-31. PubMed ID: 16301355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]